Kazia Therapeutics Cash Flow Statement (2009-2025) | KZIA

Cash Flow Statement Jun2009 Dec2009 Jun2010 Dec2010 Jun2011 Dec2011 Jun2012 Oct2012 Dec2012 Jun2013 Dec2013 Jun2014 Oct2014 Dec2014 Jun2015 Dec2015 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Operating Activities
Net Income (Quarter)
-0.01B-0.01B-0.01B
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
0.00B0.00B0.00B
Deferred Taxes (Quarter)
-0.00B-0.00B-0.00B-0.00B-0.00B
Gains from Investment Securities (Quarter)
-0.00B-0.00B0.00B
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)
-0.00B
Change in Interest Receivables (Quarter)
223.55
Change in Working Capital (Quarter)
-0.00B-0.00B
Change in Receivables (Quarter)
-0.00B0.00B0.00B
Change in Account Payables (Quarter)
0.00B-0.00B0.00B-0.00B
Other Working Capital Changes (Quarter)
0.00B0.00B-0.00B0.00B-0.00B
Cash from Operations (Quarter)
-0.01B-0.00B-0.01B-0.01B0.01B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.00B0.00B0.00B
Depreciation & Amortization (CF) (Quarter)
0.00B0.00B0.00B0.00B
Investing Activities
Capital Expenditures (Quarter)
-0.00B
Cash from Investing Activities (Quarter)
-0.01B
Financing Activities
Change in Capital Stock
Shares Issued (Quarter)
0.00B
Net Shares Issued and Repurchased (Quarter)
0.14B0.02B0.15B0.02B0.03B0.03B0.03B0.03B0.05B0.06B0.06B0.06B0.06B0.07B0.06B0.07B0.08B0.08B0.12B
Misc.
Cash from Financing Activities (Quarter)
-0.00B
Exchange Rate Effect (Quarter)
-0.00B-0.00B0.00B
Change in Cash (Quarter)
-0.01B
Beginning Cash Balance (Quarter)
0.03B
Free Cash Flow (Quarter)
-0.01B-0.00B-0.01B-0.01B0.01B
Net Cash Flow (Quarter)
-0.01B-0.00B-0.01B-0.01B0.01B